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pespite the development of several newer therapies for
patients with end-stage heart failure, including major
dvances in mechanical circulatory support, biventricular
acing, and stem cell therapies, heart transplantation remains
he gold standard.1 Although techniques for orthotopic heart
ransplant have remained fairly standard for the last several
ears, the use of donor hearts that would have been consid-
red marginal or suboptimal in previous eras has increased
such as older donors) in the current era.2 Further, the suc-
essful use of left ventricular assist devices (LVADs) as a
ridge-to-transplant has dramatically influenced not only the
umber of patients receiving a heart transplant with a LVAD
ut also reduced the number of patients receiving a heart
ransplant as a United Network for Organ Sharing status 2.3
reoperative Preparation
nce donor availability and suitability are confirmed, the
ecipient is admitted to the hospital. Relevant medical history
s taken. The medical records are reviewed; a physical exam-
nation is performed, and routine blood tests are performed.
areful attention is taken to ensuring compatibility of donor
nd recipient blood types and further immunologic compat-
bility if necessary. Noting the platelet count and prothrom-
in time is part of routine blood tests. The presence of any
ew or ongoing infection in the recipient should be ruled out.
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doi:10.1053/j.optechstcvs.2010.04.001oth of the latter issues are especially important in patients
ith LVADs since either the presence of an untreated driv-
line infection or an unexpectedly high anticoagulated state
an seriously affect the outcome of the transplant operation.
iming of Operation
t is important to carefully plan the entire operation to at-
empt to limit the donor ischemic time to less than 6 hours
nd preferably less than 4 hours. Ischemic times should also
e limited to around 4 hours or less in situations where the
onor heart is marginal (older donor) as well as in recipients
ith increased pulmonary vascular resistance. The presence
f a heart transplant coordinator at all times is essential to
acilitate a smooth and well-executed heart transplant oper-
tion. Factors that have to be considered when coordinating
iming of the operations include the following: (1) the time
hat other organ procurement teams need to complete their
issection before donor heart cross-clamping; (2) organ
ransportation time; (3) time required for the anesthesia, time
o place monitoring lines, Swan Ganz catheter, and induc-
ion; and (4) time required for recipient heart dissection and
xplantation. The timing of the recipient operation is more
ertainly more complex in patients with LVADs and/or mul-
iple sternotomies as well as in longer distance donor heart
rocurements where it is imperative that the donor heart
oes not wait for a prolonged time in the ice cooler in the
perating room, thereby increasing ischemic times. Thus,
erfect coordination of the donor and recipient operations is
ey to limiting the ex vivo donor heart ischemic time.
F
s
f
i
c
t
g
i
r
c
i
F
G
t
t
h
t
d
f
e
o
t
p
d
a
g
a
c
f
v
(
m
p
t
o
a
p
t
j
e
v
t
Orthotopic heart transplantation 139Operative Technique
igure 1 Recipient operation
etup. An overall setup similar
or other open heart operations
s adequate. Perioperative medi-
ations include the administra-
ion of antibiotics (usually first-
eneration cephalosporins) and
mmunosuppression agents. The
ecipient is usually intubated after
onfirmation that the donor heart
s suitable for transplantation. A
oley urine catheter and a Swan-
anz catheter are placed. Al-
hough all heart transplant pa-
ients on the waiting list would
ave had a right heart catheteriza-
ionduring their initial evaluation,
etermining their PA pressures
ollowing intubation might influ-
nce the need for peri- and post-
perative pulmonary vasodilator
herapy such as nitric oxide.
Standardmediansternotomy is
erformed. Preparation for car-
iopulmonary bypass includes
ctivated clotting time (ACT)-
uided heparinization and the
dministration of Amicar. Aortic
annulation should be per-
ormed as distal as possible. The
ena cavae are also cannulated
preferably with right-angled
etal tip cannulas) as distally as
ossible and umbilical caval
apes are placed.
In patientswith a prior sternot-
my, external defibrillator pads
re placed and the groin is pre-
ped for possible rapid access
o the femoral vessels in case of in-
ury to the heart during sternal re-
ntry. Ao aorta; IVC inferior
ena cava; PA  pulmonary ar-
ery; SVC superior vena cava.
140 R. John and K. LiaoFigure 2 Recipient cardiectomy. Recipient cardiectomy
is usually performed such that it is completed at the
same time that the donor heart arrives in the operating
room. The patient is placed on cardiopulmonary by-
pass; the aorta is cross-clamped and the caval snares
are tightened. The aorta and the pulmonary artery are
separated and the interatrial groove is developed. The
great vessels are divided just distal to their respective
valves. The superior vena cava is transected at the
cavo-atrial junction. A large cuff of IVC is prepared by
transecting the right atrium adjacent to the IVC (this
incision is ideally made by carrying it medially
through the ostium of the coronary sinus and laterally
through the floor of the fossa ovalis). The left atrial cuff
is prepared by entering the roof of the left atrium (this
is facilitated by the development of the interatrial
groove); this incision is extended to leave behind a
generous cuff of posterior left atrial tissue, while ob-
serving the orifices of the 4 pulmonary veins. The left
atrial appendage is also usually excised.
Following completion of the recipient cardiectomy,
it is advisable to obtain meticulous hemostasis of the
posterior pericardial region, the region adjacent to, as
well as the margins of, the left atrial cuff, as after com-
pletion of all anastomoses, these areas are extremely
hard to visualize. Ao aorta; LA left atrium; PA
pulmonary artery; SVC  superior vena cava.
Orthotopic heart transplantation 141Figure 3 Preparation of the donor heart. The aorta and pulmonary arteries are separated and the posterior pulmonary
artery attachments to the left atrium are divided. The left atrial cuff is created by connecting incisions between each of
the 4 pulmonary veins and trimming excess tissue to create a smooth continuous edge. The fossa ovalis is inspected and
probed to identify a patent foramen ovale, which can be closed by a continuous 4-0 Prolene suture from the right atrial
side. For the bicaval technique, the superior vena caval cuff is trimmed at the level of the azygous vein opening and
more if adequate recipient cuff is present. For the biatrial technique, the SVC is doubly ligated and the right atrium is
opened from the lateral IVC toward the right atrial appendage, to avoid the sinus node. Ao aorta; IVC inferior vena
cava; LA  left atrium; SVC  superior vena cava.
142 R. John and K. LiaoFigure 4 Orthotopic heart transplantation: bicaval anastomosis technique. (A) Left atrial anastomosis. The left atrial anasto-
mosis is always performed first by using a long 3-0 Prolene suture starting at the left atrial cuff adjacent to the left superior
pulmonary vein and passing it through the donor left atrial cuff adjacent to the left atrial appendage. The initial few sutures
are completed with the donor heart positioned at the level of the sternal edge and the heart is subsequently lowered into the
pericardial space. The posterior left atrial suture line is first completed and then subsequently the anterior suture line (as
shown in the figure, this is facilitated by the assistant retracting the donor aorta and PA to provide adequate exposure of the
left atrium). Tominimize the risk of left atrial thrombus formation, an everting suture technique should be done to facilitate
approximationof the smooth endocardial surfaces of donor and recipient left atrial tissue.A left ventricular vent canbepassed
through an opening between the 2 untied left atrial sutures that can help with deairing. During all the anastomosis, a cold
saline-soaked laparotomy pad can be placed on the heart. In addition, continuous carbon dioxide is also run into the
pericardial well. (B) Superior and inferior vena caval anastomosis. Next, the inferior and superior vena caval anastomoses are
usually performedwith 3-0 and 4-0 Prolene sutures, respectively. During performance of the IVC anastomosis, care is taken
to avoid deep sutures being placed in the region of the donor coronary sinus ostium to avoid potential injury. The donor right
atrial appendage is medially oriented to facilitate proper orientation of the SVC anastomosis. This is important to avoid the
SVC from being kinked or improperly aligned. Further, attention should be closely paid to avoid “purse-stringing” the SVC
anastomosis to prevent inadvertent narrowing at the anastomotic level. (C) Pulmonary artery and aortic anastomosis. It is
important to avoid excess length of pulmonary artery to avoid kinking at the level of the anastomosis. The median raphe on
the PA may help orient the anastomosis, which is performed with 4-0 Prolene suture. Next, the aortic anastomosis is
completedwith 4-0 Prolene suture. If the recipient aortic tissue quality is suboptimal, a 2-layer technique,with an inner layer
of horizontal mattress suture and outer layer of running suture, can be performed to ensure adequate hemostasis. LA left
atrium; LAA left atrial appendage; PA pulmonary artery.
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Orthotopic heart transplantation 143igure 5 Orthotopic heart transplantation:
iatrial anastomosis technique. The left
trial anastomosis is initiated as men-
ioned earlier at the base of the left atrial
ppendage adjacent to the left superior
ulmonary vein using a long 3-0 Prolene
uture. The 2 ends of the suture line are
un inferiorly and superiorly and are
ventually joined in the middle of the in-
eratrial septum. The right atrial anasto-
osis is initiated at the superior end of the
trial incision. A long 3-0 Prolene suture
s used and the suture ends are carried
oth inferiorly and superiorly to first
omplete the septal anastomosis, and
hen they are joined at the lateral wall of
he septum. The PA and aortic anastomo-
is are performed as previously described.
A  left atrium; SVC  superior vena
ava.
144 R. John and K. LiaoFigure 6 Completed orthotopic heart transplantation. After completion of all the anastomosis, IV solumedrol is admin-
istered; the patient is placed in a Trendelenburg position, and standard deairing maneuvers are performed. The aortic
cross-clamp is removed with suction on the aortic root as well as the left ventricular vent cannula. Sufficient time is
allowed for reperfusion. During this time, all suture lines are carefully inspected for hemostasis, especially areas such
as the left atrial suture line that would be extremely difficult to inspect after cardiopulmonary bypass is terminated.
Right atrial and right ventricular temporary pacing wires are placed. Appropriate inotropic support is also initiated
during the period of reperfusion. The need for aggressive pulmonary vasodilator therapy including nitric oxide may be
required for certain recipients. Standard deairing maneuvers are performed and confirmed by transesophageal echo-
cardiography. The patient is subsequently weaned off cardiopulmonary bypass in the usual manner. Intraoperative
transesophageal echocardiography is also utilized to confirm adequate functioning of the implanted heart and docu-
ment ventricular function as well as valvar competence. Standard chest tubes are placed, including adequate drainage
of the posterior pericardial space, as these patients are at increased risk of developing postoperative pericardial effusions
because of the relative size mismatch between the donor heart and the relatively large pericardial space.
Sequence of implant anastomosis. For both bicaval and biatrial techniques, the left atrial anastomosis is always
performed first. This is usually followed by the inferior vena cava (IVC), superior vena cava (SVC), pulmonary artery
(PA), and aortic anastomosis in the bicaval technique. However, in situations inwhich the donor ischemic time is longer
than anticipated, the aortic anastomosis can be performed with release of the cross-clamp before the SVC and PA
anastomosis. Similarly for the biatrial technique, the aortic anastomosis and release of cross-clamp can be done after the
left atrial anastomosis, and the PA and right atrial anastomosis can be performed subsequently.
Orthotopic heart transplantation 145Figure 7 Orthotopic heart transplantation with LVAD explant. An increasing number of patients are being bridged to a heart
transplant through the use of a LVAD.4,5 As a heart transplant in patients with LVADs is more complex, strategies at the time
of LVAD placement might facilitate safer LVAD explant at the time of heart transplantation. The LVAD outflow graft should
be directed toward the right atrial gutter so as to avoid injuring it during sternal re-entry. Further, the outflow graft
anastomosis should be placed on the lateral aspect of the aorta as proximal as possible so as to leave adequate room for both
aortic cannulation as well as the aortic anastomosis during the subsequent transplant. The plane between the aorta and the
pulmonary artery is also preferably left undisturbed to allow easier dissection around the aorta at the time of subsequent
transplant. It is ideal to avoid the use of Teflon pledgets at cannulation sites at the time of LVAD placement as this might
reduce the degree of scarring. The use of various protective barriers to prevent injury to the right ventricle during resternot-
omy such as Gor-Tex mesh or Cormatrix is increasingly being used. Although unclear at this point in time, the use of some
protective barriers might favorably influence the degree of scarring and adhesion formation and thereby facilitate easier
dissection of the heart and LVAD for explant. There is also an increased role for the use of femoral cannulation for
cardiopulmonary bypass in patients undergoing heart transplantation with ventricular assist devices to avoid potentially
catastrophic outflow graft injury. In some patients, the use of femoral artery cannulation might limit the need for extensive
dissection of the ascending aorta, especially if the combination of the outflow graft location and a relatively short ascending
aorta might otherwise warrant cannulation of the aorta further distal on the aortic arch.
Bleeding is often a significant problem inpatients undergoingheart transplantationwith LVADexplant, partly from the fact that
these patients have often had multiple prior sternotomies as well as because that these patients with the newer continuous flow
LVADs are anticoagulatedwithWarfarin. It is ourpractice to commonly administer intravenous vitaminKand fresh frozenplasma
topartially reverse the anticoagulationbeforeproceeding to theoperating room.Despite carefulmeasures toobtainhemostasis, it is
sometimes necessary to leave to chest open and packed and return in 24 to 48 hours for subsequent chest closure.
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146 R. John and K. Liaoonclusions
oth the bicaval and the biatrial technique can be safely per-
ormedwith excellent long-termoutcomes in patientswith end-
tage heart failure. Numerous studies have been performed
omparing both these techniques with varied results. The bica-
al technique preserves normal atrial morphology, sinus node
unction, and valvular function.6 As a result, it has consistently
een associatedwith a decreased incidence of atrial arrhythmias
nd the need for pacemaker implantation. However, potential
isadvantages include an increased ischemic time and the pos-
ibility of narrowing of the caval anastomosis. A relatively con-
tant number of cardiac donors over the past decade have re-
ulted in the increased use of marginal donors as well as
ncreased numbers of patients undergoing transplants after be-
ng bridged with a LVAD. This has certainly increased the com-
lexity of the heart transplant operation, and thus, critical atten-
ion to the pre- and intraoperative phases of this procedure is
ssential for excellent long-term outcomes.eferences
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